These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7478593)

  • 21. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
    Bell SM; Zuo J; Myers RM; Knowles MA
    Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer.
    Yang X; Shen P; Yao K; Mi Z; Liu S; Zhang H; Wang D; Liu C; Liu H
    Chin Med J (Engl); 2000 Feb; 113(2):117-9. PubMed ID: 11775532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of two regions on chromosome 4 in bladder carcinoma: definition of a critical 750kB region at 4p16.3.
    Elder PA; Bell SM; Knowles MA
    Oncogene; 1994 Dec; 9(12):3433-6. PubMed ID: 7970702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1995 Jan; 55(2):224-7. PubMed ID: 7812948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion mapping in squamous cell carcinomas of the esophagus defines a region containing a tumor suppressor gene within a 4-centimorgan interval of the distal long arm of chromosome 9.
    Miura K; Okita K; Furukawa Y; Matsuno S; Nakamura Y
    Cancer Res; 1995 May; 55(9):1828-30. PubMed ID: 7728747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
    Knowles MA; Shaw ME; Proctor AJ
    Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for two bladder cancer suppressor loci on human chromosome 9.
    Ruppert JM; Tokino K; Sidransky D
    Cancer Res; 1993 Nov; 53(21):5093-5. PubMed ID: 8221642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1994 Mar; 54(6):1422-4. PubMed ID: 8137242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.
    van Tilborg AA; de Vries A; Zwarthoff EC
    J Pathol; 2001 May; 194(1):76-80. PubMed ID: 11329144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
    Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y
    Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detailed deletion map of chromosomal arm 9q in esophageal squamous cell carcinoma].
    Miura K; Nakamura Y
    Nihon Rinsho; 1996 Apr; 54(4):986-91. PubMed ID: 8920661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.
    Devlin J; Elder PA; Gabra H; Steel CM; Knowles MA
    Br J Cancer; 1996 Feb; 73(4):420-3. PubMed ID: 8595153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.
    Merlo A; Gabrielson E; Mabry M; Vollmer R; Baylin SB; Sidransky D
    Cancer Res; 1994 May; 54(9):2322-6. PubMed ID: 8162574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.